Michelangelo Russillo

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

Violeta Serra, Maurizio Scaltriti, Ludmila Prudkin et al. · Oncogene · 2011 · 530 citations · Full text

Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine

Giulio Metro, Jennifer Foglietta, Michelangelo Russillo et al. · Annals of Oncology · 2010 · 167 citations

Neuro-oncology, Breast Oncology, Brain Metastases +9

Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center

Alessandra Fabi, Alessandra Felici, Giulio Metro et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 118 citations · Full text

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials

Valentina Rossi, Paola Berchialla, Diana Giannarelli et al. · Cancers · 2019 · 67 citations · Full text

The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey

Vincenzo Di Noia, Davide Renna, Vittoria Barberi et al. · European Journal of Cancer · 2021 · 56 citations · Full text

Vaccination, Preventive Medicine, Solid Cancer +9